» Articles » PMID: 27355080

Effect of 82% Lactic Acid in Treatment of Melasma

Overview
Specialty Biology
Date 2016 Jun 30
PMID 27355080
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Melasma is an acquired, chronic, and symmetrical hypermelanosis, characterized by brown patches of variable darkness on sun exposed areas of body. There are numerous modalities of treatment currently in use for this disease, of which the chemical peeling is very commonly used. Therefore, the present work was done to see the effect of 82% lactic acid peel in the treatment of melasma. A total number of 20 patients of either sex attending the OPD of dermatology department with clinically evident melasma were included in the study. 82% Lactic acid peel was applied on the face for 12 weeks in each patient. Patients were evaluated clinically and photographically at various intervals and in follow-up till 24 weeks. Assessment of patient satisfaction and side effects were also noted. All the subjects completed the study. Application of this peel for 12 weeks significantly decreased the melasma area severity index score and also melasma severity scale score. Patient and physician analogue scales also showed the improvement by the treatment. Regarding the adverse effects, burning sensation was the only side effect noted in our study. In conclusion, 82% lactic acid peel is well tolerated and can be used for the treatment of melasma.

Citing Articles

Potential Application of Camel Milk as a Therapeutic Ingredient in Bath Soaps and Shampoos.

Oginga E, Toeri J, Marete E, Arimi J Dermatol Res Pract. 2024; 2024:4846339.

PMID: 39219666 PMC: 11364480. DOI: 10.1155/2024/4846339.


Lactic Acid Chemical Peeling in Skin Disorders.

Feng X, Shang J, Gu Z, Luo X, Chen Y, Liu Y Clin Cosmet Investig Dermatol. 2024; 17:901-909.

PMID: 38682041 PMC: 11055559. DOI: 10.2147/CCID.S455700.


Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.

Pietowska Z, Nowicka D, Szepietowski J Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231404 PMC: 9564742. DOI: 10.3390/ijerph191912084.


Update on Melasma-Part II: Treatment.

Cassiano D, Esposito A, da Silva C, Lima P, Dias J, Hassun K Dermatol Ther (Heidelb). 2022; 12(9):1989-2012.

PMID: 35906506 PMC: 9464276. DOI: 10.1007/s13555-022-00780-4.


Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals.

Juncan A, Moisa D, Santini A, Morgovan C, Rus L, Vonica-Tincu A Molecules. 2021; 26(15).

PMID: 34361586 PMC: 8347214. DOI: 10.3390/molecules26154429.


References
1.
Pandya A, Guevara I . Disorders of hyperpigmentation. Dermatol Clin. 2000; 18(1):91-8, ix. DOI: 10.1016/s0733-8635(05)70150-9. View

2.
Duffy D . Alpha hydroxy acids/trichloroacetic acids risk/benefit, strategies. A photographic review. Dermatol Surg. 1998; 24(2):181-9; quiz 190-1. DOI: 10.1111/j.1524-4725.1998.tb04135.x. View

3.
Sarvjot V, Sharma S, Mishra S, Singh A . Melasma: a clinicopathological study of 43 cases. Indian J Pathol Microbiol. 2009; 52(3):357-9. DOI: 10.4103/0377-4929.54993. View

4.
Balkrishnan R, McMichael A, Camacho F, Saltzberg F, Housman T, Grummer S . Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003; 149(3):572-7. DOI: 10.1046/j.1365-2133.2003.05419.x. View

5.
Javaheri S, Handa S, Kaur I, Kumar B . Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001; 40(5):354-7. DOI: 10.1046/j.1365-4362.2001.01149.x. View